| Phase 17 trials |
|
Phase 1
|
NCT06156241 |
Jan 2024 → Dec 2025 |
post-COVID-19 disorder |
Charles Cox |
Unknown
|
No outcome recorded
|
|
Phase 1
|
NCT02245711 |
Dec 2010 → Jan 2015 |
limb-girdle muscular dystrophy |
Neurogen Brain and Spine Institute |
Withdrawn
|
No outcome recorded
|
|
Phase 1
|
NCT02241434 |
Jan 2009 → Jan 2016 |
Duchenne muscular dystrophy |
Neurogen Brain and Spine Institute |
Withdrawn
|
No outcome recorded
|
|
Phase 1
|
NCT02241928 |
Jan 2009 → Dec 2018 |
muscular dystrophy |
Neurogen Brain and Spine Institute |
Withdrawn
|
No outcome recorded
|
|
Phase 1
|
NCT02245776 |
Dec 2008 → Jun 2018 |
nervous system disorder |
Neurogen Brain and Spine Institute |
Withdrawn
|
No outcome recorded
|
|
Phase 1
|
NCT02242071 |
Dec 2008 → Mar 2015 |
amyotrophic lateral sclerosis |
Neurogen Brain and Spine Institute |
Withdrawn
|
No outcome recorded
|
|
Phase 1
|
NCT02245698 |
Dec 2008 → Jun 2018 |
stroke disorder |
Neurogen Brain and Spine Institute |
Withdrawn
|
No outcome recorded
|
| Phase 1/23 trials |
|
Phase 1/2
|
NCT01834066 |
Sep 2014 → Nov 2016 |
Duchenne muscular dystrophy |
Chaitanya Hospital, Pune |
Unknown
|
No outcome recorded
|
|
Phase 1/2
|
NCT02151890 |
Mar 2012 → May 2014 |
primary ovarian failure |
Al-Azhar University |
Completed
|
No outcome recorded
|
|
Phase 1/2
|
NCT02372474 |
Mar 2012 → Dec 2014 |
primary ovarian failure |
Al-Azhar University |
Completed
|
No outcome recorded
|
| Phase not applicable1 trial |
| — |
NCT06391307 |
May → Nov 2024 |
pilonidal sinus |
Mustafa Azizoğlu |
Unknown
|
No outcome recorded
|
| Comparator or background therapy1 trial |
| — |
NCT02315235 Comparator |
May 2014 → Mar 2016 |
diabetic neuropathy |
Seoul National University Hospital |
Withdrawn
|
No outcome recorded
|